Authors:
GALLEN M
ALONSO C
OJEDA B
VILADIU P
BELTRAN M
BORRAS J
PELEGRI A
TUSQUETS I
BARNADAS A
ARCUSA A
BASTUS R
BALIL A
BATISTEALENTORN E
BOLEDA M
BADIA MA
GARAU I
GUASH I
Citation: M. Gallen et al., RANDOMIZED TRIAL OF 2 VERSUS 4 YEARS OF ADJUVANT TAMOXIFEN (AT) FOR POSTMENOPAUSAL WOMEN WITH NODE-POSITIVE BREAST-CANCER, European journal of cancer, 34, 1998, pp. 101-101
Authors:
PELEGRI A
BARNADAS A
ESCOBEDO A
RIFA J
MARTIN J
LAINEZ N
GIL M
BELLET M
ROSELL R
BORRAS J
Citation: A. Pelegri et al., ADJUVANT DOX -] CMF IN PATIENTS WITH BREAST-CANCER (BC) AND 4 OR MOREPOSITIVE NODES (GREATER-THAN-OR-EQUAL-TO-4- CAN MILAN TRIAL RESULTS BE REPRODUCED IN CLINICAL SETTING(LN) ), Annals of oncology, 9, 1998, pp. 27-27
Authors:
LOBO F
MENDEZ M
BARNADAS A
BUSQUIER I
LIZON J
PROVENCIO M
ALBISTUR J
MARTINEZ P
SANCHEZ MJ
CONSTELA M
DIAZ FJ
DEMOSTOLES HG
PUJOL HGTI
DECASTELLON HG
SANJUAN H
DEHIERRO CP
Citation: F. Lobo et al., IPHOSPHAMIDE(I) PLUS VINORELBINE (VRB) IN METASTATIC BREAST-CANCER PATIENTS PREVIOUSLY TREATED WITH COMBINATION CHEMOTHERAPY - PRELIMINARY-RESULTS OF A PHASE-II TRIAL, Annals of oncology, 9, 1998, pp. 134-134
Authors:
PIFARRE A
MONZO M
MARTIN C
SANCHEZ JJ
BARNADAS A
ROSELL R
Citation: A. Pifarre et al., CLINICAL IMPLICATIONS OF TELOMERASE ACTIVITY IN NONSMALL CELL LUNG-CANCER (NSCLC), Annals of oncology, 9, 1998, pp. 444-444
Authors:
SANCHEZCESPEDES M
ROSELL R
PIFARRE A
LOPEZCABRERIZO MP
BARNADAS A
SANCHEZ JJ
LORENZO JC
ABAD A
MONZO M
NAVASPALACIOS JJ
Citation: M. Sanchezcespedes et al., MICROSATELLITE ALTERATIONS AT 5Q21, 11P13, AND 11P15.5 DO NOT PREDICTSURVIVAL IN NONSMALL CELL LUNG-CANCER, Clinical cancer research, 3(7), 1997, pp. 1229-1235
Authors:
TABERNERO JM
DELMURO XG
ALBA E
SANCHEZ M
APARICIO J
BARNADAS A
MONTESINOS J
MARTINEZ M
GERMA JR
Citation: Jm. Tabernero et al., BOMP EPI INTENSIVE CHEMOTHERAPY IN POOR-PROGNOSIS GERM-CELL TUMORS (GCT)/, European journal of cancer, 33, 1997, pp. 161-161
Authors:
BARNADAS A
MENDIOLA C
CASADO A
VILLAR A
JIMENO J
CLERIGUE M
ROSELL R
DIAZRUBIO E
CORTESFUNES H
DEPAREDES MG
Citation: A. Barnadas et al., COMBINATION OF ORAL IDARUBICIN AND PREDNIMUSTINE IN ADVANCED BREAST-CANCER - A PHASE-II STUDY, European journal of cancer, 33(2), 1997, pp. 312-315
Authors:
MARTIN M
LLUCH A
OJEDA B
BARNADAS A
COLOMER R
MASSUTI B
BENITO D
Citation: M. Martin et al., PACLITAXEL PLUS DOXORUBICIN IN METASTATIC BREAST-CANCER - PRELIMINARY-ANALYSIS OF CARDIOTOXICITY, Seminars in oncology, 24(5), 1997, pp. 26-30
Authors:
ELLIS GK
HUTCHINS L
JIMENEZMARTIN M
PECORA AL
BARNADAS A
MEISENBERG B
NABHOLTZ JM
CORTESFUNES H
RIFKIN R
CHANG AYC
GARRISON L
GEORGE C
GILES FJ
Citation: Gk. Ellis et al., PHASE-III DOUBLE-BLIND RANDOMIZED STUDY OF PIXY321 VERSUS GCSF AFTER CEP FOR BREAST OR OVARIAN-CARCINOMA, Blood, 88(10), 1996, pp. 1783-1783
Authors:
ABAD A
GARCIA P
GRAVALOS C
TUSQUETS I
FONT A
PEREZ G
CORTESFUNES H
FABREGAT X
BARNADAS A
ROSELL R
Citation: A. Abad et al., SEQUENTIAL METHOTREXATE, 5-FLUOROURACIL (5-FU), AND HIGH-DOSE LEUCOVORIN VERSUS 5-FU AND HIGH-DOSE LEUCOVORIN VERSUS 5-FU ALONE FOR ADVANCED COLORECTAL-CANCER - A MULTIINSTITUTIONAL RANDOMIZED TRIAL, Cancer, 75(6), 1995, pp. 1238-1244
Authors:
AGUDO A
BARNADAS A
PALLARES C
MARTINEZ I
FABREGAT X
ROSELLO J
ESTAPE J
PLANAS J
GONZALEZ CA
Citation: A. Agudo et al., LUNG-CANCER AND CIGARETTE-SMOKING IN WOMEN - A CASE-CONTROL STUDY IN BARCELONA (SPAIN), International journal of cancer, 59(2), 1994, pp. 165-169
Authors:
ROSELL R
LI SR
SKACEL Z
MATE JL
MAESTRE J
CANELA M
TOLOSA E
ARMENGOL P
BARNADAS A
ARIZA A
Citation: R. Rosell et al., PROGNOSTIC IMPACT OF MUTATED K-RAS GENE IN SURGICALLY RESECTED NONSMALL CELL LUNG-CANCER PATIENTS, Oncogene, 8(9), 1993, pp. 2407-2412
Authors:
CARLES J
ROSELL R
ARIZA A
PELLICER I
SANCHEZ JJ
FERNANDEZVASALO G
ABAD A
BARNADAS A
Citation: J. Carles et al., NEUROENDOCRINE DIFFERENTIATION AS A PROGNOSTIC FACTOR IN NONSMALL CELL LUNG-CANCER, Lung cancer, 10(3-4), 1993, pp. 209-219
Authors:
ESCUDERO D
BARNADAS A
CODINA M
FUEYO J
GRAUS F
Citation: D. Escudero et al., ANTI-RI-ASSOCIATED PARANEOPLASTIC NEUROLOGIC DISORDER WITHOUT OPSOCLONUS IN A PATIENT WITH BREAST-CANCER, Neurology, 43(8), 1993, pp. 1605-1606